Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 22, 2013- Sarilumab, Given Subcutaneously Every Other Week, Met All Three Co-Primary Endpoints -
-
Sep 24, 2013- Findings Consistent with Known Post-Prandial Effect of Lyxumia Supporting Combination with Basal Insulin -
-
Jul 31, 2013- Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children -